[go: up one dir, main page]

SE0001865D0 - Management of septic shock - Google Patents

Management of septic shock

Info

Publication number
SE0001865D0
SE0001865D0 SE0001865A SE0001865A SE0001865D0 SE 0001865 D0 SE0001865 D0 SE 0001865D0 SE 0001865 A SE0001865 A SE 0001865A SE 0001865 A SE0001865 A SE 0001865A SE 0001865 D0 SE0001865 D0 SE 0001865D0
Authority
SE
Sweden
Prior art keywords
septic shock
pharmaceutical composition
management
sterile pharmaceutical
medicament
Prior art date
Application number
SE0001865A
Other languages
English (en)
Swedish (sv)
Inventor
Arne Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0001865A priority Critical patent/SE0001865D0/xx
Publication of SE0001865D0 publication Critical patent/SE0001865D0/xx
Priority to US09/849,591 priority patent/US20020037933A1/en
Priority to AU2001254990A priority patent/AU2001254990A1/en
Priority to BR0110982-0A priority patent/BR0110982A/pt
Priority to CN01809726A priority patent/CN1430509A/zh
Priority to PCT/GB2001/002117 priority patent/WO2001087289A2/fr
Priority to KR1020027015536A priority patent/KR20020097482A/ko
Priority to EP01928126A priority patent/EP1296664A2/fr
Priority to IL15247101A priority patent/IL152471A0/xx
Priority to CA002407540A priority patent/CA2407540A1/fr
Priority to MXPA02011240A priority patent/MXPA02011240A/es
Priority to JP2001583757A priority patent/JP2003533476A/ja
Priority to ZA200208893A priority patent/ZA200208893B/en
Priority to NO20025530A priority patent/NO20025530L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0001865A 2000-05-19 2000-05-19 Management of septic shock SE0001865D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock
US09/849,591 US20020037933A1 (en) 2000-05-19 2001-05-07 Management of septic shock
JP2001583757A JP2003533476A (ja) 2000-05-19 2001-05-15 敗血症ショックの治療
KR1020027015536A KR20020097482A (ko) 2000-05-19 2001-05-15 패혈증 치료용 프로포폴
BR0110982-0A BR0110982A (pt) 2000-05-19 2001-05-15 Composição farmacêutica estéril para administração parenteral, uso do composto 2,6-diisopropil-fenol (propofol), uso de uma composição farmacêutica estéril para administração parenteral, método de manejo do choque séptico, e, método de contraposição à deterioração induzida por endotoxina da tensão de oxigênio arterial
CN01809726A CN1430509A (zh) 2000-05-19 2001-05-15 控制败血症性休克
PCT/GB2001/002117 WO2001087289A2 (fr) 2000-05-19 2001-05-15 Gestion de choc septique
AU2001254990A AU2001254990A1 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
EP01928126A EP1296664A2 (fr) 2000-05-19 2001-05-15 Gestion de choc septique
IL15247101A IL152471A0 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
CA002407540A CA2407540A1 (fr) 2000-05-19 2001-05-15 Gestion de choc septique
MXPA02011240A MXPA02011240A (es) 2000-05-19 2001-05-15 Manejo de choque septico.
ZA200208893A ZA200208893B (en) 2000-05-19 2002-11-01 Propofol for treatment of sepsis.
NO20025530A NO20025530L (no) 2000-05-19 2002-11-18 Håndtering av septisk sjokk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock

Publications (1)

Publication Number Publication Date
SE0001865D0 true SE0001865D0 (sv) 2000-05-19

Family

ID=20279747

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock

Country Status (14)

Country Link
US (1) US20020037933A1 (fr)
EP (1) EP1296664A2 (fr)
JP (1) JP2003533476A (fr)
KR (1) KR20020097482A (fr)
CN (1) CN1430509A (fr)
AU (1) AU2001254990A1 (fr)
BR (1) BR0110982A (fr)
CA (1) CA2407540A1 (fr)
IL (1) IL152471A0 (fr)
MX (1) MXPA02011240A (fr)
NO (1) NO20025530L (fr)
SE (1) SE0001865D0 (fr)
WO (1) WO2001087289A2 (fr)
ZA (1) ZA200208893B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU759641B2 (en) * 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
KR20070087004A (ko) * 2002-04-08 2007-08-27 엠쥐아이 쥐피, 아이엔씨. 프로포폴의 수용성 프로드럭을 함유하는 약제학적 조성물및 그것을 투여하는 방법
WO2003105817A1 (fr) * 2002-05-02 2003-12-24 Fdl, Inc. Nouvelle composition parenterale a base de propofol
AU2006310113A1 (en) * 2005-08-05 2007-05-10 Bharat Serums & Vaccines Ltd. Intravenous propofol emulsion compositions having preservative efficacy
US7727730B2 (en) * 2005-12-09 2010-06-01 Corgenix Medical Corporation Methods and kits for detection of thromboxane A2 metabolites
WO2011161687A1 (fr) * 2010-06-23 2011-12-29 Harman Finochem Limited Procédé pour la préparation de 2,6-diisopropylphénol extra pur
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
CN109470762B (zh) * 2017-09-07 2020-12-29 中国科学院大连化学物理研究所 一种准确识别丙泊酚注射液是否过期的方法
US20220008499A1 (en) * 2018-11-15 2022-01-13 Ferring B.V. Compounds, compositions and methods for treating sepsis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
MXPA02011240A (es) 2003-03-10
IL152471A0 (en) 2003-05-29
JP2003533476A (ja) 2003-11-11
CA2407540A1 (fr) 2001-11-22
US20020037933A1 (en) 2002-03-28
ZA200208893B (en) 2004-02-19
NO20025530L (no) 2003-01-14
WO2001087289A2 (fr) 2001-11-22
KR20020097482A (ko) 2002-12-31
NO20025530D0 (no) 2002-11-18
WO2001087289A3 (fr) 2002-05-16
CN1430509A (zh) 2003-07-16
BR0110982A (pt) 2003-04-08
AU2001254990A1 (en) 2001-11-26
EP1296664A2 (fr) 2003-04-02

Similar Documents

Publication Publication Date Title
BR9907832A (pt) Composição de propofol contendo sulfito
BR9913221A (pt) Composições catalisadoras sustentadas altamente ativas
BR0317822A (pt) Composição fluoroquìmica
BR0010242A (pt) Composições quìmicas que atraem artrópodes
IS2750B (is) Leiðarafesting
SE0301888D0 (sv) New use VII
PA8486001A1 (es) Composiciones de celecoxib
UY26092A1 (es) Uso de inhibidores de cyp2d6 en terapias de combinacion
SE0301886D0 (sv) New use V
PA8548001A1 (es) Derivados aromaticos de acidos dicarboxilicos
ID28263A (id) DIPEPTIDA OKSAMIL TERMODIFIKASI C-TERMINAL SEBAGAI PENGHAMBAT PADA KELUARGA ICE-ced-3 DARI PROTEASE SISTEINA
SE0301882D0 (sv) New use I
DE60236117D1 (de) Phosphattransporthemmer
TNSN06359A1 (fr) Aryl-ou heteroaryl-amides substitues en position ortho
SE0001865D0 (sv) Management of septic shock
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
KR960700217A (ko) 액체 페놀성 산화방지제
BR0000544A (pt) Poliolefinas de metaloceno estabilizadas
ATE468381T1 (de) Neuer kraftstoff mit hoher oktanzahl und geringem aromatengehalt
ATE538124T1 (de) Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit
ATE516031T1 (de) Verbindungen gegen krebs
AR043253A1 (es) 4-[(2,4-dicloro-5-metoxifenil)amino] -6- alcoxi-3-quinolina carbonitrilos para el tratamiento de lesiones isquemicas
ECSP066548A (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica
BR9508342A (pt) Compostos orgânicos
CO5280199A1 (es) Composicion